CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Reagents
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Instruments
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Software And Services
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Enzyme-linked Immunosorbent Assay
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Chemiluminescence Immunoassay
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Fluorescent Immunoassay
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Radioimmunoassay
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: IMMUNODIAGNOSTICS MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Infectious Diseases
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Oncology Endocrinology
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Bone Mineral Diseases
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Autoimmunity Disorders
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Cardiac Biomarkers
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Drug Monitoring
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Others
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
CHAPTER 7: IMMUNODIAGNOSTICS MARKET, BY END-USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End-user
7.2. Hospitals
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Clinical Laboratories
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Academic Research Institutes
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Others
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
CHAPTER 8: IMMUNODIAGNOSTICS MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product Type
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End-user
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Immunodiagnostics Market
8.2.7.1. Market Size and Forecast, By Product Type
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End-user
8.2.8. Canada Immunodiagnostics Market
8.2.8.1. Market Size and Forecast, By Product Type
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End-user
8.2.9. Mexico Immunodiagnostics Market
8.2.9.1. Market Size and Forecast, By Product Type
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End-user
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product Type
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End-user
8.3.6. Market Size and Forecast, By Country
8.3.7. France Immunodiagnostics Market
8.3.7.1. Market Size and Forecast, By Product Type
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End-user
8.3.8. Germany Immunodiagnostics Market
8.3.8.1. Market Size and Forecast, By Product Type
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End-user
8.3.9. Italy Immunodiagnostics Market
8.3.9.1. Market Size and Forecast, By Product Type
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End-user
8.3.10. Spain Immunodiagnostics Market
8.3.10.1. Market Size and Forecast, By Product Type
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End-user
8.3.11. UK Immunodiagnostics Market
8.3.11.1. Market Size and Forecast, By Product Type
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End-user
8.3.12. Rest Of Europe Immunodiagnostics Market
8.3.12.1. Market Size and Forecast, By Product Type
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End-user
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product Type
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End-user
8.4.6. Market Size and Forecast, By Country
8.4.7. China Immunodiagnostics Market
8.4.7.1. Market Size and Forecast, By Product Type
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End-user
8.4.8. Japan Immunodiagnostics Market
8.4.8.1. Market Size and Forecast, By Product Type
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End-user
8.4.9. India Immunodiagnostics Market
8.4.9.1. Market Size and Forecast, By Product Type
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End-user
8.4.10. South Korea Immunodiagnostics Market
8.4.10.1. Market Size and Forecast, By Product Type
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End-user
8.4.11. Australia Immunodiagnostics Market
8.4.11.1. Market Size and Forecast, By Product Type
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End-user
8.4.12. Rest of Asia-Pacific Immunodiagnostics Market
8.4.12.1. Market Size and Forecast, By Product Type
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End-user
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product Type
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End-user
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Immunodiagnostics Market
8.5.7.1. Market Size and Forecast, By Product Type
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End-user
8.5.8. South Africa Immunodiagnostics Market
8.5.8.1. Market Size and Forecast, By Product Type
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End-user
8.5.9. Saudi Arabia Immunodiagnostics Market
8.5.9.1. Market Size and Forecast, By Product Type
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End-user
8.5.10. Rest of LAMEA Immunodiagnostics Market
8.5.10.1. Market Size and Forecast, By Product Type
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End-user
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping Of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Abbott
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. Becton Dickinson
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies, Inc.
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Exact Sciences Corporation
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Guardant Health
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Illumina, Inc.
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. Diaosorin
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. NeoGenomics Laboratories
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. F. Hoffmann-La Roche Ltd.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Thermo Fisher Scientific
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 2. IMMUNODIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. IMMUNODIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. IMMUNODIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. GLOBAL IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 6. IMMUNODIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. IMMUNODIAGNOSTICS MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. IMMUNODIAGNOSTICS MARKET FOR FLUORESCENT IMMUNOASSAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. IMMUNODIAGNOSTICS MARKET FOR RADIOIMMUNOASSAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. IMMUNODIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. GLOBAL IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 12. IMMUNODIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. IMMUNODIAGNOSTICS MARKET FOR ONCOLOGY ENDOCRINOLOGY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. IMMUNODIAGNOSTICS MARKET FOR BONE MINERAL DISEASES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. IMMUNODIAGNOSTICS MARKET FOR AUTOIMMUNITY DISORDERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. IMMUNODIAGNOSTICS MARKET FOR CARDIAC BIOMARKERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 17. IMMUNODIAGNOSTICS MARKET FOR DRUG MONITORING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 18. IMMUNODIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 19. GLOBAL IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 20. IMMUNODIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 21. IMMUNODIAGNOSTICS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 22. IMMUNODIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 23. IMMUNODIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 24. IMMUNODIAGNOSTICS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 25. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 26. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 27. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 28. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 30. U.S. IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 31. U.S. IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 32. U.S. IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 33. U.S. IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 34. CANADA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 35. CANADA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 36. CANADA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 37. CANADA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 38. MEXICO IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 39. MEXICO IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 40. MEXICO IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. MEXICO IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 42. EUROPE IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 43. EUROPE IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 44. EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 45. EUROPE IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 46. EUROPE IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 47. FRANCE IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 48. FRANCE IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 49. FRANCE IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 50. FRANCE IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 51. GERMANY IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 52. GERMANY IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 53. GERMANY IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. GERMANY IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 55. ITALY IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 56. ITALY IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 57. ITALY IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 58. ITALY IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 59. SPAIN IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 60. SPAIN IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 61. SPAIN IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 62. SPAIN IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 63. UK IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 64. UK IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 65. UK IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. UK IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 67. REST OF EUROPE IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 68. REST OF EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 69. REST OF EUROPE IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 70. REST OF EUROPE IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 71. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 72. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 73. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 74. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 75. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 76. CHINA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 77. CHINA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 78. CHINA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. CHINA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 80. JAPAN IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 81. JAPAN IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 82. JAPAN IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 83. JAPAN IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 84. INDIA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 85. INDIA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 86. INDIA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 87. INDIA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 88. SOUTH KOREA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 89. SOUTH KOREA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 90. SOUTH KOREA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 91. SOUTH KOREA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 92. AUSTRALIA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 93. AUSTRALIA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 94. AUSTRALIA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 95. AUSTRALIA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 96. REST OF ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 97. REST OF ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 98. REST OF ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 99. REST OF ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 100. LAMEA IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 101. LAMEA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 102. LAMEA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 103. LAMEA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 104. LAMEA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 105. BRAZIL IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 106. BRAZIL IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 107. BRAZIL IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 108. BRAZIL IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 109. SOUTH AFRICA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 110. SOUTH AFRICA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 111. SOUTH AFRICA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 112. SOUTH AFRICA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 113. SAUDI ARABIA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 114. SAUDI ARABIA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 115. SAUDI ARABIA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 116. SAUDI ARABIA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 117. REST OF LAMEA IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024 - 2033 ($BILLION)
TABLE 118. REST OF LAMEA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 119. REST OF LAMEA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 120. REST OF LAMEA IMMUNODIAGNOSTICS MARKET, BY END-USER, 2024 - 2033 ($BILLION)
TABLE 121. ABBOTT: KEY EXECUTIVES
TABLE 122. ABBOTT: COMPANY SNAPSHOT
TABLE 123. ABBOTT: OPERATING SEGMENTS
TABLE 124. ABBOTT: PRODUCT PORTFOLIO
TABLE 125. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126. BECTON DICKINSON: KEY EXECUTIVES
TABLE 127. BECTON DICKINSON: COMPANY SNAPSHOT
TABLE 128. BECTON DICKINSON: OPERATING SEGMENTS
TABLE 129. BECTON DICKINSON: PRODUCT PORTFOLIO
TABLE 130. BECTON DICKINSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
TABLE 132. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 133. AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 134. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 135. AGILENT TECHNOLOGIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136. EXACT SCIENCES CORPORATION: KEY EXECUTIVES
TABLE 137. EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 138. EXACT SCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 139. EXACT SCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 140. EXACT SCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 141. GUARDANT HEALTH: KEY EXECUTIVES
TABLE 142. GUARDANT HEALTH: COMPANY SNAPSHOT
TABLE 143. GUARDANT HEALTH: OPERATING SEGMENTS
TABLE 144. GUARDANT HEALTH: PRODUCT PORTFOLIO
TABLE 145. GUARDANT HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 146. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 147. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 148. ILLUMINA, INC.: OPERATING SEGMENTS
TABLE 149. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 150. ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 151. DIAOSORIN: KEY EXECUTIVES
TABLE 152. DIAOSORIN: COMPANY SNAPSHOT
TABLE 153. DIAOSORIN: OPERATING SEGMENTS
TABLE 154. DIAOSORIN: PRODUCT PORTFOLIO
TABLE 155. DIAOSORIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 156. NEOGENOMICS LABORATORIES: KEY EXECUTIVES
TABLE 157. NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT
TABLE 158. NEOGENOMICS LABORATORIES: OPERATING SEGMENTS
TABLE 159. NEOGENOMICS LABORATORIES: PRODUCT PORTFOLIO
TABLE 160. NEOGENOMICS LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 161. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 162. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 163. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 164. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 165. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 166. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
TABLE 167. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 168. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 169. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 170. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL IMMUNODIAGNOSTICS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF IMMUNODIAGNOSTICS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN IMMUNODIAGNOSTICS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALIMMUNODIAGNOSTICS MARKET
FIGURE 10. GLOBAL IMMUNODIAGNOSTICS MARKET SEGMENTATION, BY PRODUCT TYPE
FIGURE 11. IMMUNODIAGNOSTICS MARKET FOR REAGENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. IMMUNODIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. IMMUNODIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL IMMUNODIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY
FIGURE 15. IMMUNODIAGNOSTICS MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. IMMUNODIAGNOSTICS MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. IMMUNODIAGNOSTICS MARKET FOR FLUORESCENT IMMUNOASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. IMMUNODIAGNOSTICS MARKET FOR RADIOIMMUNOASSAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. IMMUNODIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. GLOBAL IMMUNODIAGNOSTICS MARKET SEGMENTATION, BY APPLICATION
FIGURE 21. IMMUNODIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. IMMUNODIAGNOSTICS MARKET FOR ONCOLOGY ENDOCRINOLOGY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. IMMUNODIAGNOSTICS MARKET FOR BONE MINERAL DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. IMMUNODIAGNOSTICS MARKET FOR AUTOIMMUNITY DISORDERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 25. IMMUNODIAGNOSTICS MARKET FOR CARDIAC BIOMARKERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 26. IMMUNODIAGNOSTICS MARKET FOR DRUG MONITORING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 27. IMMUNODIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 28. GLOBAL IMMUNODIAGNOSTICS MARKET SEGMENTATION, BY END-USER
FIGURE 29. IMMUNODIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 30. IMMUNODIAGNOSTICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 31. IMMUNODIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 32. IMMUNODIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 33. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 34. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 35. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 36. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 37. COMPETITIVE DASHBOARD
FIGURE 38. COMPETITIVE HEATMAP: IMMUNODIAGNOSTICS MARKET
FIGURE 39. TOP PLAYER POSITIONING, 2023
FIGURE 40. ABBOTT: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. ABBOTT: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. ABBOTT: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. BECTON DICKINSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. BECTON DICKINSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. BECTON DICKINSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. AGILENT TECHNOLOGIES, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. EXACT SCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. EXACT SCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. EXACT SCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. GUARDANT HEALTH: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. GUARDANT HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. GUARDANT HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. ILLUMINA, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. ILLUMINA, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 58. DIAOSORIN: NET SALES, 2021-2023 ($BILLION)
FIGURE 59. DIAOSORIN: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 60. DIAOSORIN: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 61. NEOGENOMICS LABORATORIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 62. NEOGENOMICS LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 63. NEOGENOMICS LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 64. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 65. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 66. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 67. THERMO FISHER SCIENTIFIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 68. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 69. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2023 (%)
